Back to Corient Private Wealth LP Corient Private Wealth LP

ERNAERNA
5 quarters

Position history for Corient Private Wealth LPCorient Private Wealth LP's holdings in ERNEXA THERAPEUTICS INC

Corient Private Wealth LP previously held 0 shares of ERNA (ERNEXA THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$32,242

Total Shares Change

-17,523

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$6.65
0
2026-Q1
Decreased
438,093
-50.0%
$87,1810.0%$0.30
0
2025-Q4
Increased
876,184
+100.0%
$1.1M0.0%$1.17
40
2025-Q3
Increased
438,092
+2400.1%
$479,7110.0%$1.17
39
2025-Q2
New
17,523
-
$32,2420.0%$1.85
30

Other major holders of ERNA: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used